Search
Assembly Biosciences Inc
ASMBAdd to Watchlist
27.740USD
+1.050+3.93%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
549.72MMarket Cap
303.30P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Assembly Biosciences Inc is 9.00, ranking 17 out of 387 in the Biotechnology & Medical Research industry. The average price target is 39.50, with a high of 50.00 and a low of 35.00.
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
48.750
Target Price
+82.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Assembly Biosciences Inc
ASMB
4
Beigene Ltd
ONC
27
Ionis Pharmaceuticals Inc
IONS
27
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Assembly Biosciences Inc's expected revenue for the next quarter?
Assembly Biosciences Inc's expected revenue is 8.60M.
What is Assembly Biosciences Inc's price target?
Analysts forecast that Assembly Biosciences Inc's price target is USD 39.50, with the highest forecast at USD 50.00 and the lowest forecast at USD 35.00.
How have Assembly Biosciences IncASMB's recent earnings per share performed?
The market expectation was USD -0.54, while Assembly Biosciences IncASMB's earnings per share (EPS) for the previous quarter was USD 1.30. EPS for the next quarter is expected at USD -0.62.
What is the analyst rating for Assembly Biosciences Inc?
Based on the ratings of Assembly Biosciences Inc's stock from 4 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.